Use of evidence-based therapy for the prevention of cardiovascular events among older people

Evaluation and the Health Professions

Volumn 33, Issue 3, 2010, Pages 276-301

  Castelino, Ronald L ^a   Chen, Timothy F ^a   Guddattu, Vasudev ^b   Bajorek, Beata V ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b MANIPAL UNIVERSITY   (India)

Author keywords

cardiovascular disease; evidence based therapies; home medicines review; older people; pharmacists

Indexed keywords

ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

AGE; AGED; AGING; ARTICLE; ATTITUDE TO HEALTH; AUSTRALIA; CARDIOVASCULAR DISEASE; COMMUNITY CARE; CONFIDENCE INTERVAL; CROSS-SECTIONAL STUDY; DRUG USE; EVIDENCE BASED MEDICINE; FEMALE; HEALTH CARE POLICY; HUMAN; MALE; METHODOLOGY; PHARMACIST; PREVALENCE; RETROSPECTIVE STUDY; RISK; RISK ASSESSMENT; STATISTICAL MODEL; STATISTICS;

ADRENERGIC BETA-ANTAGONISTS; AGE FACTORS; AGED, 80 AND OVER; AGING; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; CARDIOVASCULAR DISEASES; COMMUNITY HEALTH SERVICES; CONFIDENCE INTERVALS; CROSS-SECTIONAL STUDIES; DRUG UTILIZATION REVIEW; EVIDENCE-BASED MEDICINE; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH POLICY; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LOGISTIC MODELS; MALE; NEW SOUTH WALES; ODDS RATIO; PHARMACISTS; PREVALENCE; RETROSPECTIVE STUDIES; RISK ASSESSMENT;

EID: 77956067146     PISSN: 01632787     EISSN: 15523918     Source Type: Journal    
DOI: 10.1177/0163278710374854     Document Type: Article

References (66)

1. Alexander, K.P., Roe, M.T., Chen, A.Y., Lytle, B.L., Pollack, C.V., Jr., Foody, J.M.,... Peterson, E.D. (2005). Evolution in cardiovascular care for elderly patients with non-ST-segment elevation acute coronary syndromes: Results from the CRUSADE National Quality Improvement Initiative. Journal of the American College of Cardiology, 46, 1479-1487.
2. Ali, R.C., Melloni, C., Ou, F.-S., Schmader, K., Ohman, E.M., Roe, M.T., Alexander, K.P. (2009). Age and persistent use of cardiovascular medication after acute coronary syndrome: Results from medication applied and sustained over time. Journal of the American Geriatrics Society, 57, 1990-1996.
3. Bajorek, B.V., Krass, I., Ogle, S.J., Duguid, M.J., & Shenfield, G.M. (2002). The impact of age on antithrombotic use in elderly patients with non-valvular atrial fibrillation. Australasian Journal on Ageing, 21, 36-41.
4. Bajorek, B.V., Krass, I., Ogle, S.J., Duguid, M.J., & Shenfield, G.M. (2005). Optimizing the use of antithrombotic therapy for atrial fibrillation in older people: A pharmacist-led multidisciplinary intervention. Journal of the American Geriatrics Society, 53, 1912-1920.
5. Blomkalns, A.L., Chen, A.Y., Hochman, J.S., Peterson, E.D., Trynosky, K., Diercks, D.B.,... Newby, L.K. (2005). Gender disparities in the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes: Large-scale observations from the CRUSADE (Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes With Early Implementation of the American College of Cardiology/American Heart Association Guidelines) National Quality Improvement Initiative. Journal of the American College of Cardiology, 45, 832-837.
6. Brugts, J.J., Yetgin, T., Hoeks, S.E., Gotto, A.M., Shepherd, J., Westendorp, R.G.J.,... Deckers, J.W. (2009). The benefits of statins in people without established cardiovascular disease but with cardiovascular risk factors: Meta-analysis of randomised controlled trials. British Medical Journal, 338, b2376.
7. Campbell Research & Consulting. (2008). Home Medicines Review Program Qualitative Research Project. Final Report. Department of Health & Ageing, Australia. Retrieved April 28, 2010, from http://www.health.gov.au/internet/main/publishing.nsf/Content/B2992EBF12BE7E1ECA2573D8007F91F3/$File/HMR%20Final%20Report.pdf.
8. Castelino, R.L., Bajorek, B.V., & Chen, T.F. (2009). Targeting suboptimal prescribing in the elderly: A review of the impact of pharmacy services. Annals of Pharmacotherapy, 43, 1096-1106.
9. Castelino, R.L., Bajorek, B.V., & Chen, T.F. (2010). Are interventions recommended by pharmacists during Home Medicines Review evidence-based? Journal of Evaluation in Clinical Practice. In press.
10. Castelino, R.L., Hilmer, S.N., Bajorek, B.V., Nishtala, P., & Chen, T.F. (2010). Drug Burden Index and potentially inappropriate medications in community-dwelling older people: The impact of Home Medicines Review. Drugs & Aging, 27, 135-148.
11. Chew, D.P., Amerena, J., Coverdale, S., Rankin, J., Astley, C., & Brieger, D. (2007). Current management of acute coronary syndromes in Australia: Observations from the acute coronary syndromes prospective audit. Internal Medicine Journal, 37, 741-748.
12. De Berardis, G., Sacco, M., Strippoli, G.F.M., Pellegrini, F., Graziano, G., Tognoni, G., & Nicolucci, A. (2009). Aspirin for primary prevention of cardiovascular events in people with diabetes: Meta-analysis of randomised controlled trials. British Medical Journal, 339, b4531.
13. Department of Health and Ageing, Australian Government, 2001. Medication Management Reviews. Retrieved February 15, 2010, from http://www.health.gov.au/internet/main/publishing.nsf/Content/health-epc-dmmr-answers.htm#6.
14. Elliott, R.A., Woodward, M.C., & Oborne, C.A. (2002). Antithrombotic prescribing in atrial fibrillation: Application of a prescribing indicator and multidisciplinary feedback to improve prescribing. Age & Ageing, 31, 391-396.
15. Gage, B.F., Boechler, M., Doggette, A.L., Fortune, G., Flaker, G.C., Rich, M.W., & Radford, M.J. (2000). Adverse outcomes and predictors of underuse of antithrombotic therapy in medicare beneficiaries with chronic atrial fibrillation. Stroke, 31, 822-827.
16. Gilbert, A.L., Roughead, E.E., Beilby, J., Mott, K., & Barratt, J.D. (2002). Collaborative medication management services: Improving patient care. Medical Journal of Australia, 177, 189-192.
17. Grundy, S.M., Pasternak, R., Greenland, P., Smith, S., Jr., & Fuster, V. (1999). AHA/ACC scientific statement: Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations: A statement for healthcare professionals from the American Heart Association and the American College of Cardiology. Journal of the American College of Cardiology, 34, 1348-1359.
18. Hanlon, J.T., Schmader, K.E., Ruby, C.M., & Weinberger, M. (2001). Suboptimal prescribing in older inpatients and outpatients. Journal of the American Geriatrics Society, 49, 200-209.
19. Heeley, E.L., Peiris, D.P., Patel, A.A., Cass, A., Weekes, A., Morgan, C., Chalmers, J.P. (2010). Cardiovascular risk perception and evidence--practice gaps in Australian general practice (the AusHEART study) Medical Journal of Australia, 192, 254-259.
20. Hennekens, C.H., Dyken, M.L., & Fuster, V. (1997). Aspirin as a therapeutic agent in cardiovascular disease: A statement for healthcare professionals from the American Heart Association. Circulation, 96, 2751-2753.
21. Hlatky, M.A. (2004). Underuse of evidence-based therapies. Circulation, 110, 644-645.
22. Ho, P.M., Spertus, J.A., Masoudi, F.A., Reid, K.J., Peterson, E.D., Magid, D.J.,... Rumsfeld, J.S. (2006). Impact of medication therapy discontinuation on mortality after myocardial infarction. Archives of Internal Medicine, 166, 1842-1847.
23. Hobbs, F.D., Jones, M.I., Allan, T.F., Wilson, S., & Tobias, R. (2000). European survey of primary care physician perceptions on heart failure diagnosis and management (Euro-HF). European Heart Journal, 21, 1877-1887.
24. Holland, R., Desborough, J., Goodyer, L., Hall, S., Wright, D., & Loke, Y.K. (2008). Does pharmacist-led medication review help to reduce hospital admissions and deaths in older people? A systematic review and meta-analysis. British Journal of Clinical Pharmacology, 65, 303-316.
25. Huynh, L.T., Phillips, P.A., & Chew, D.P. (2007). Improving the management of acute coronary syndromes in Australia: Translating evidence to outcomes. Internal Medicine Journal, 37, 412-415.
26. Jackevicius, C.A., Anderson, G.M., Leiter, L., & Tu, J.V. (2001). Use of the statins in patients after acute myocardial infarction: Does evidence change practice? Archives of Internal Medicine, 161, 183-188.
27. Jackevicius, C.A., Tu, K., Filate, W.A., Brien, S.E., & Tu, J.V. (2003). Trends in cardiovascular drug utilization and drug expenditures in Canada between 1996 and 2001. Canadian Journal of Cardiology, 19, 1359-1366.
28. Klungel, O.H., Heckbert, S.R., de Boer, A., Leufkens, H.G.M., Sullivan, S.D., Fishman, P.A.,... Pasty. B.M. (2002). Lipid-lowering drug use and cardiovascular events after myocardial infarction. Annals of Pharmacotherapy, 36, 751-757.
29. Krumholz, H.M., Radford, M.J., Wang, Y., Chen, J., Heiat, A., & Marciniak, T.A. (1998). National use and effectiveness of beta-blockers for the treatment of elderly patients after acute myocardial infarction: National Cooperative Cardiovascular Project. Journal of the American Medical Association, 280, 623-629.
30. Lakatta, E.G. (2000). Cardiovascular aging in health. Clinics in Geriatric Medicine, 16, 419-444.
31. Lee, P.Y., Alexander, K.P., Hammill, B.G., Pasquali, S.K., & Peterson, E.D. (2001). Representation of elderly persons and women in published randomized trials of acute coronary syndromes. Journal of the American Medical Association, 286, 708-713.
32. Lewis, W.R., Ellrodt, A.G., Peterson, E., Hernandez, A.F., LaBresh, K.A., Cannon, C.P.,... Fonarow. G. C. (2009). Trends in the use of evidence-based treatments for coronary artery disease among women and the elderly: Findings from the get with the guidelines quality-improvement program. Circulation: Cardiovascular Quality and Outcomes, 2, 633-641.
33. Lough, M., Cleland, J., Langan, J., Cowley, A., & Wade, A. (1998). Initiating angiotensin converting enzyme inhibitors in mild to moderate heart failure in general practice: Randomised, placebo controlled trial. British Medical Journal, 317, 1352-1353.
34. Miller, M., Byington, R., Hunninghake, D., Pitt, B., & Furberg, C.D. (2000). Sex bias and underutilization of lipid-lowering therapy in patients with coronary artery disease at academic medical centers in the United States and Canada. Prospective Randomized Evaluation of the Vascular Effects of Norvasc Trial (PREVENT) InvestigatorsArchives of Internal Medicine, 160, 343-347.
35. National Blood Pressure and Vascular Disease Advisory Committee, National Heart Foundation of Australia. (2008). Guide to the management of hypertension 2008. Canberra: NHF. Retrieved April 29, 2010, from http://www.heartfoundation.org.au/SiteCollectionDocuments/A_Hypert_Guidelines2008_2009Update_FINAL.pdf.
36. National Heart Foundation of Australia and Cardiac Society of Australia and New Zealand 2006. (2006). Guidelines for the prevention, detection and management of chronic heart failure in Australia. Canberra: NHF. Retrieved April 29, 2010, from http://www.heartfoundation.org.au/SiteCollectionDocuments/CHF%202006%20Guidelines%20NHFA-CSANZ%20WEB.pdf.
37. National Heart Foundation of Australia and Cardiac Society of Australia and New Zealand. (2004). Reducing risk in heart disease 2004: Guidelines for preventing cardiovascular events in people with coronary heart disease. Canberra: NHF.
38. National Heart Foundation of Australia and Cardiac Society of Australia and New Zealand. (2007). Reducing risk in heart disease 2007: Guidelines for preventing cardiovascular events in people with coronary heart disease. Canberra: NHF. Retrieved April 29, 2010, from http://www.heartfoundation.org.au/SiteCollectionDocuments/A%20RR%20RRIHD%202008Update%20Guideline%20pdf.pdf.
39. National Institute of Clinical Studies. (2003). Evidence-practice gaps report. (Vol. 1). Melbourne, Victoria: National Institute of Clinical Studies.
40. Nishtala, P.S., McLachlan, A.J., Bell, J.S., & Chen, T.F. (2010). A retrospective study of drug-related problems in Australian aged care homes: Medication reviews involving pharmacists and general practitioners. Journal of Evaluation in Clinical Practice. In press.
41. Pearson, T.A., Blair, S.N., Daniels, S.R., Eckel, R.H., Fair, J.M., Fortmann, S.P.,... Taubert, K.A. (2002). AHA guidelines for primary prevention of cardiovascular disease and stroke: 2002 update: Consensus panel guide to comprehensive risk reduction for adult patients without coronary or other atherosclerotic vascular diseases. American Heart Association Science Advisory and Coordinating Committee. Circulation, 106, 388-391.
42. Pharmacy Guild of Australia. (2009). Medication management review program. Canberra: Author. Retrieved April 28, 2010, from http://www.guild.org.au/mmr/.
43. Phillips, S.M., Marton, R.L., & Tofler, G.H. (2004). Barriers to diagnosing and managing heart failure in primary care. Medical Journal of Australia, 181, 78-81.
44. Pilote, L., Beck, C.A., Karp, I., Alter, D., Austin, P., Cox, J.,... Tu, J.V. (2004). Secondary prevention after acute myocardial infarction in four Canadian provinces, 1997-2000. Canadian Journal of Cardiology, 20, 61-67.
45. Rasmussen, J.N., Chong, A., & Alter, D.A. (2007). Relationship between adherence to evidence-based pharmacotherapy and long-term mortality after acute myocardial infarction. Journal of the American Medical Association, 297, 177-186.
46. Rathore, S.S., Mehta, R.H., Wang, Y., Radford, M.J., & Krumholz, H.M. (2003). Effects of age on the quality of care provided to older patients with acute myocardial infarction. American Journal of Medicine, 114, 307-315.
47. Rojas-Fernandez, C.H., Kephart, G.C., Sketris, I.S., & Kass, K. (1999). Underuse of acetylsalicylic acid in individuals with myocardial infarction, ischemic heart disease or stroke: Data from the 1995 population-based Nova Scotia Health Survey. Canadian Journal of Cardiology, 15, 291-296.
48. Roughead, E.E., Barratt, J.D., Ramsay, E., Pratt, N., Ryan, P., Peck, R.,... Gilbert, A. L. (2009). The effectiveness of collaborative medicine reviews in delaying time to next hospitalization for patients with heart failure in the practice setting: Results of a cohort study. Circulation: Heart Failure, 2, 424-428.
49. Soumerai, S.B., McLaughlin, T.J., Spiegelman, D., Hertzmark, E., Thibault, G., & Goldman, L. (1997). Adverse outcomes of underuse of beta-blockers in elderly survivors of acute myocardial infarction. Journal of the American Medical Association, 277, 115-121.
50. Spertus, J.A., Kettelkamp, R., Vance, C., Decker, C., Jones, P.G., Rumsfeld, J.S.,... Cohen, D.J. (2006). Prevalence, predictors, and outcomes of premature discontinuation of thienopyridine therapy after drug-eluting stent placement: Results from the PREMIER registry. Circulation, 113, 2803-2809.
51. Stafford, R.S., & Radley, D.C. (2003). The underutilization of cardiac medications of proven benefit, 1990 to 2002. Journal of the American College of Cardiology, 41, 56-61.
52. Tapson, V.F., Hyers, T.M., Waldo, A.L., Ballard, D.J., Becker, R.C., Caprini, J.A.,... Shillington, A.C. (2005). Antithrombotic therapy practices in US hospitals in an era of practice guidelines. Archives of Internal Medicine, 165, 1458-1464.
53. Therapeutic Guidelines Limited. (2007). Therapeutic guidelines: Neurology (3rd ed.). Melbourne: Author.
54. Therapeutic Guidelines Limited. (2008). Therapeutic guidelines: Cardiovascular (5th ed.). Melbourne: Author.
55. Tran, C.T.T., Laupacis, A., Mamdani, M.M., & Tu, J.V. (2004). Effect of age on the use of evidence-based therapies for acute myocardial infarction. American Heart Journal, 148, 834-841.
56. Tu, K., Mamdani, M.M., Jacka, R.M., Forde, N.J., Rothwell, D.M., & Tu, J.V. (2003). The striking effect of the Heart Outcomes Prevention Evaluation (HOPE) on ramipril prescribing in Ontario. CMAJ Canadian Medical Association Journal, 168, 553-557.
57. Vale, M.J., Jelinek, M.V., Best, J.D., & COACH study group; Coaching patients on Achieving Cardiovascular Health. (2002). How many patients with coronary heart disease are not achieving their risk-factor targets? Experience in Victoria 1996-1998 versus 1999-2000. Medical Journal of Australia, 176, 211-215.
58. Vermeer, N.S., & Bajorek, B.V. (2008). Utilization of evidence-based therapy for the secondary prevention of acute coronary syndromes in Australian practice. Journal of Clinical Pharmacy & Therapeutics, 33, 591-601.
59. Webster, R.J., Heeley, E.L., Peiris, D.P., Bayram, C., Cass, A., & Patel, A.A. (2009). Gaps in cardiovascular disease risk management in Australian general practice. Medical Journal of Australia, 191, 324-329.
60. Weekes, L.M., Mackson, J.M., Fitzgerald, M., & Phillips, S.R. (2005). National Prescribing Service: Creating an implementation arm for national medicines policy. British Journal of Clinical Pharmacology, 59, 112-116.
61. Wolff, T., Miller, T., & Ko, S. (2009). Aspirin for the primary prevention of cardiovascular events: an update of the evidence for the U.S. Preventive Services Task Force. Annals of Internal Medicine, 150, 405-410.
62. Wong, C.-K., Newby, L.K., Bhapker, M.V., Aylward, P.E., Pfisterer, M., Alexander, K.P.,... White, H.D. (2007). Use of evidence-based medicine for acute coronary syndromes in the elderly and very elderly: Insights from the Sibrafiban vs aspirin to yield maximum protection from ischemic heart events postacute coronary syndromes trials. American Heart Journal, 154, 313-321.
63. World Health Organization. (1992). International statistical classification of disease and related health problems (10th rev.). Geneva: Author[online]. Retrieved December 1, 2009, fromhttp://apps.who.int/classifications/apps/icd/icd10online/ [Accessed 2009 Dec 1].
64. World Health Organization. (2009). WHO Collaborating Centre for Drug Statistics Methodology. ATC classification index with DDDs. Oslo: Author[online]. Retrieved December 1, 2009, from http://www.whocc.no/atcddd/.
65. Wright, R.M., Sloane, R., Pieper, C.F., Ruby-Scelsi, C., Twersky, J., Schmader, K.E., & Hanlon, J.T. (2009). Underuse of indicated medications among physically frail older US veterans at the time of hospital discharge: results of a cross-sectional analysis of data from the Geriatric Evaluation and Management Drug Study. American Journal of Geriatric Pharmacotherapy, 7, 271-280.
66. Yarzebski, J., Spencer, F., Goldberg, R.J., Lessard, D., & Gore, J.M. (2001). Temporal trends (1986-1997) in cholesterol level assessment and management practices in patients with acute myocardial infarction: A population-based perspective. Archives of Internal Medicine, 161, 1521-1528.